Namenda
Term · Oncology and biomedicine · MLC-T-ONC-005660
A drug used to treat dementia caused by Alzheimer disease. It is also being studied in the treatment of side effects from whole-brain radiation therapy for cancer and other conditions. Namenda blocks the uptake of calcium by certain brain cells and decreases their activity. It is a type of N-methyl-D-asparatate (NMDA) receptor antagonist. Also called memantine hydrochloride.
| Identifier | MLC-T-ONC-005660 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | memantine hydrochloride |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-005660",
"term": "Namenda",
"field": "Oncology and biomedicine",
"definition": "A drug used to treat dementia caused by Alzheimer disease. It is also being studied in the treatment of side effects from whole-brain radiation therapy for cancer and other conditions. Namenda blocks the uptake of calcium by certain brain cells and decreases their activity. It is a type of N-methyl-D-asparatate (NMDA) receptor antagonist. Also called memantine hydrochloride.",
"synonyms": [
"memantine hydrochloride"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/namenda/"
}
Record 11,561 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.